What the research actually shows Let us look at what clinical studies and prescribing data tell us about injection site significance
This process is often referred to as body recomposition
Nausea, Tolerance, and Individual Variation in Semaglutide Response About 2535% of patients report mild to moderate nausea during the first 48 weeks of semaglutide therapy, regardless of what they eat
This article has been viewed 536,062 times
1,500 mg is about halfway to the high-end of dosage used in clinical research, so would seem to be a good starting point
Khoury CK, Bjorkman AD, Dempewolf H, Ramirez-Villegas J, Guarino L, Jarvis A et al (2014) Increasing homogeneity in global food supplies and the implications for food security